S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in
OTCMKTS:PVTTF

Pivotal Therapeutics Stock Forecast, Price & News

$0.05
0.00 (0.00 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.04
Now: $0.05
$0.16
50-Day Range
$0.01
MA: $0.03
$0.05
52-Week Range
$0.00
Now: $0.05
$0.16
Volume11,000 shs
Average Volume20,227 shs
Market Capitalization$4.49 million
P/E RatioN/A
Dividend YieldN/A
Beta1.01
Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PVTTF
CUSIPN/A
CIKN/A
Phone905-856-9797
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$4.49 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.58 out of 5 stars

Medical Sector

1378th out of 1,968 stocks

Pharmaceutical Preparations Industry

609th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.05
0.00 (0.00 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PVTTF News and Ratings via Email

Sign-up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pivotal Therapeutics (OTCMKTS:PVTTF) Frequently Asked Questions

What stocks does MarketBeat like better than Pivotal Therapeutics?

Wall Street analysts have given Pivotal Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pivotal Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Pivotal Therapeutics' stock price been impacted by Coronavirus (COVID-19)?

Pivotal Therapeutics' stock was trading at $0.0035 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PVTTF shares have increased by 1,295.7% and is now trading at $0.0489.
View which stocks have been most impacted by COVID-19
.

Who are Pivotal Therapeutics' key executives?

Pivotal Therapeutics' management team includes the following people:
  • Ms. Rachelle MacSweeney, Co-Founder, CEO, Pres & Director
  • Mr. George Jackowski, Co-Founder, Chief Scientific Officer & Director (Age 70)

Who are some of Pivotal Therapeutics' key competitors?

What is Pivotal Therapeutics' stock symbol?

Pivotal Therapeutics trades on the OTCMKTS under the ticker symbol "PVTTF."

How do I buy shares of Pivotal Therapeutics?

Shares of PVTTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pivotal Therapeutics' stock price today?

One share of PVTTF stock can currently be purchased for approximately $0.05.

How much money does Pivotal Therapeutics make?

Pivotal Therapeutics has a market capitalization of $4.49 million.

What is Pivotal Therapeutics' official website?

The official website for Pivotal Therapeutics is www.pivotaltherapeutics.us.

How can I contact Pivotal Therapeutics?

The company can be reached via phone at 905-856-9797.


This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.